Native Microfluidic CE-MS Analysis of Antibody Charge Heterogeneity
Copyright © Targeted News Service 2024
2024-12-17
ALEXANDRIA, Virginia, Dec. 17 -- REGENERON PHARMACEUTICALS, INC., Tarrytown, New York has been assigned a patent (No. US 12169203 B2, initially filed Jan. 30, 2020) developed by three inventors Hongxia Wang, Briarcliff Manor, New York; Haibo Qiu, Hartsdale, New York; and Ning Li, New Canaan, Connecticut, for "Native microfluidic CE-MS analysis of antibody charge heterogeneity." . . .